Archives
-
Canagliflozin and Renal Mitochondrial Remodeling
2026-10-04
Canagliflozin is a selective SGLT2 inhibitor whose research relevance extends beyond glucose lowering to proximal-tubule mitochondrial biology. This article examines the evidence, sex-specific findings, translational boundaries, and interpretive value of a 2025 hypertensive-diabetic mouse study.
-
Rapamycin and mTOR Signaling in Uveal Melanoma
2026-10-03
Rapamycin, also known as Sirolimus, is a research tool for studying FKBP12-associated mTOR signaling, autophagy, metabolism, and immunosuppression. In uveal melanoma, Liu et al. reported that PTK6 promotes proliferation, migration, and invasion while increasing mTOR phosphorylation and suppressing autophagy. These findings establish a biologically relevant PTK6–SOCS3–mTOR relationship, but they do not by themselves demonstrate that rapamycin is an effective uveal melanoma treatment. Evidence from lens epithelial cells and a Leigh syndrome mitochondrial disease model is informative for pathway biology, yet remains model-specific.
-
MK-1775 Workflow for Wee1 Checkpoint Studies
2026-10-02
Build more informative Wee1 inhibitor experiments by separating cell-cycle arrest from true cell killing. This practical MK-1775 workflow combines checkpoint biomarkers, p53-aware model selection, combination scheduling, and troubleshooting for reproducible cancer research.
-
Tetracycline: Designing Mechanism-Safe Assays
2026-10-01
Tetracycline is more than a broad-spectrum polyketide antibiotic: it is a controlled perturbation whose effects must be separated from disease-specific biology. This guide connects its ribosomal mechanism and handling requirements with assay-design lessons from LKB1–telomerase research.
-
GW 4869: Probing Exosome-Driven Osteogenesis
2026-10-01
GW 4869 provides a mechanistic way to test whether neutral sphingomyelinase-dependent extracellular-vesicle release contributes to lithium-enhanced osteogenesis. This article connects the compound’s sphingolipid biology with exosomal Wnt10a, Rab11a trafficking, β-catenin signaling, and translational bone-regeneration workflows.
-
Testosterone Bounce and Degarelix in Prostate Cancer
2026-09-30
A 2024 study found that a testosterone bounce, defined by recovery above 20 ng/dL after suppression below that threshold, was associated with longer overall and cancer-specific survival in patients receiving degarelix. The work highlights serial testosterone behavior as a potentially informative biomarker while showing that its prognostic value may differ across survival endpoints.
-
Quercetin: A Multi-Pathway Assay Strategy
2026-09-30
Quercetin is more than a PI3K inhibitor: it can help researchers distinguish mitochondrial apoptosis from ferroptosis. This evidence-led guide translates a recent Wilson disease study into practical assay and interpretation decisions for cancer research.
-
hCG, H3K27 Methylation, and Decidual CXCL10
2026-09-29
The reference study shows that human chorionic gonadotropin suppresses CXCL10 in human decidual cells through EZH2-associated deposition of H3K27me3 at a defined promoter region. This establishes a mechanistic link between trophoblast-derived endocrine signaling, chromatin state, and CD8 cell recruitment at the maternal–fetal interface.
-
DiscoveryProbe™ Metabolism-related Compound Library
2026-09-29
This article provides a practical workflow for using SKU L1032 as a standardized panel for metabolic enzyme, pathway, and cell-based screening. It is intended for research use in in vitro and ex vivo systems only; it should not be treated as evidence for clinical, diagnostic, or therapeutic use.
-
Gly-Gly-Phe-Gly (GGFG) Workflow Guide
2026-09-28
Gly-Gly-Phe-Gly (GGFG) is a compact, flexible peptide spacer for controlled conjugation between targeting biomolecules and functional payloads. This guide translates its 98% research-grade specification into practical workflows for drug conjugation research, antibody-drug conjugate development, peptide engineering, and biomaterial construction.
-
Indole-3-pyruvic acid: Reliable Assay Workflows
2026-09-28
Learn how to use Indole-3-pyruvic acid (IPA, SKU C8759) thoughtfully in cell-based experiments, from assay controls and concentration planning to handling and data interpretation. The guide distinguishes product information from published evidence and offers practical criteria for selecting and comparing IPA sources.
-
ERAD Hijacking Enables Transmembrane Protein Degradation
2026-09-27
Song and colleagues introduce ERAD-engaging chimeras (ERADECs), which redirect transmembrane targets to endoplasmic-reticulum-associated degradation. Their desonide-based design achieved potent PD-L1 degradation and tumor suppression in preclinical experiments, while also suggesting broader uses for ERAD recruitment.
-
Cell Senescence β-Galactosidase Staining Kit Guide
2026-09-26
Use a visible SA-β-Gal endpoint to map senescence in stimulated macrophages, cellular aging models, or frozen tissue sections. This guide connects the Tp47 inflammatory-senescence findings to a practical staining workflow, with controls and troubleshooting that help distinguish a useful phenotype from a standalone mechanistic claim.
-
LL-37 Mimetics Show Selective Antibiofilm Activity
2026-09-25
Luo and colleagues compared LL-37 with the truncated mimetics KE-18 and KR-12, showing that improved planktonic antimicrobial activity does not necessarily translate into activity against established biofilms. Their paired biomass and metabolic assays highlight why antimicrobial susceptibility and antibiofilm effects should be measured and interpreted separately.
-
α2-AR Agonism in Osteosarcoma Recurrence Research
2026-09-25
A recent study evaluates UK14,304 delivered in a thermosensitive hydrogel as a strategy to reduce osteosarcoma recurrence after surgery. Its findings point to immune-mediated tumor control, including CD8+ T-cell and TCR-signaling involvement, while leaving important questions about mechanism, delivery, and clinical transferability unresolved.